Unique ID issued by UMIN | UMIN000004452 |
---|---|
Receipt number | R000005329 |
Scientific Title | Phase I clinical trial of peptide vaccine with UFT/LV for advanced or recurrent colorectal cancer |
Date of disclosure of the study information | 2010/10/27 |
Last modified on | 2012/10/31 15:53:56 |
Phase I clinical trial of peptide vaccine with UFT/LV for advanced or recurrent colorectal cancer
Phase I clinical trial of peptide vaccine with UFT/LV for colorectal cancer
Phase I clinical trial of peptide vaccine with UFT/LV for advanced or recurrent colorectal cancer
Phase I clinical trial of peptide vaccine with UFT/LV for colorectal cancer
Japan |
advanced or recurrent colorectal cancer
Gastrointestinal surgery |
Malignancy
YES
We performed phase I clinical trial of the peptide vaccine therapy together with anticancer drug for the advanced colorectal cancer to confirm the safety of the treatment.
Efficacy
We confirm the safety of the peptide vaccine against colorectal cancer patient.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Vaccine |
Peptide vaccine therapy
20 | years-old | <= |
80 | years-old | >= |
Male and Female
Performance Status 0-1
Refractory to standard therapy
Pregnancy
Uncontrolled infection
Patients with serious concomitant disease
10
1st name | |
Middle name | |
Last name | Masakazu Yamamoto |
Tokyo Women's Medical University
Department of gastroenterological surgery
8-1, Kawata-cho, Shinjuku-ku, Tokyo
1st name | |
Middle name | |
Last name |
Tokyo Women's Medical University
Department of gastroenterological surgery
03-3353-8111
Tokyo Women's Medical University
human Genome Center, Institute of Medical Science, University of Tokyo
Self funding
NO
2010 | Year | 10 | Month | 27 | Day |
Partially published
Completed
2008 | Year | 05 | Month | 13 | Day |
2008 | Year | 07 | Month | 01 | Day |
2010 | Year | 10 | Month | 26 | Day |
2012 | Year | 10 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005329